Sema4 Holdings Corp
NASDAQ:SMFR
Sema4 Holdings Corp
Capital Expenditures
Sema4 Holdings Corp
Capital Expenditures Peer Comparison
Competitive Capital Expenditures Analysis
Latest Figures & CAGR of Competitors
Company | Capital Expenditures | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
S
|
Sema4 Holdings Corp
NASDAQ:SMFR
|
Capital Expenditures
-$14.3m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
DaVita Inc
NYSE:DVA
|
Capital Expenditures
-$541.3m
|
CAGR 3-Years
7%
|
CAGR 5-Years
11%
|
CAGR 10-Years
1%
|
|
Quest Diagnostics Inc
NYSE:DGX
|
Capital Expenditures
-$385m
|
CAGR 3-Years
3%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
-4%
|
|
CVS Health Corp
NYSE:CVS
|
Capital Expenditures
-$2.8B
|
CAGR 3-Years
-3%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
-3%
|
|
Cigna Corp
NYSE:CI
|
Capital Expenditures
-$1.5B
|
CAGR 3-Years
-11%
|
CAGR 5-Years
-19%
|
CAGR 10-Years
-10%
|
|
Laboratory Corporation of America Holdings
NYSE:LH
|
Capital Expenditures
-$493.5m
|
CAGR 3-Years
-10%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
-9%
|
See Also
What is Sema4 Holdings Corp's Capital Expenditures?
Capital Expenditures
-14.3m
USD
Based on the financial report for Dec 31, 2022, Sema4 Holdings Corp's Capital Expenditures amounts to -14.3m USD.
What is Sema4 Holdings Corp's Capital Expenditures growth rate?
Capital Expenditures CAGR 1Y
31%
Over the last year, the Capital Expenditures growth was 31%.